Combined VEGF/PDGF Improves Olfactory Regeneration After Unilateral Bulbectomy in Mice

Overview

Journal Neural Regen Res

Date 2018 Aug 24

PMID 30136698

Citations 7

Authors

Kate Beecher

Louise M Hafner

Jenny Ekberg

James A St John

Fatemeh Chehrehasa

Affiliations

Soon will be listed here.

Abstract

The olfactory receptor neurons lining the nasal cavity have a remarkable capacity to regenerate throughout life. They are replenished continuously and their axons make new connections within the olfactory bulb. However, some factors such as head trauma and skull base surgery damage the olfactory nerve which lead to olfactory dysfunction. Losing the sense of smell has considerable effects on quality of life and life-expectancy. Therefore, there is a clear need to find a treatment for olfactory dysfunction. One such potential treatment is growth factor therapy which showed promising results in the spinal cord and brain injuries. The aim of the present study was to investigate whether combined delivery of two growth factors, vascular endothelial growth factor and platelet-derived growth factor treatment can improve the olfactory neurons regeneration in mice. The degeneration of the olfactory neurons was induced by unilateral bulbectomy. The treatment group received 1.5 µg of the combined growth factors intranasally, while the control injured group received saline. Growth factor treatment significantly increased the number of immature neurons at 5 and 7 days post injury and also the number of mature olfactory neurons at 10 and 14 days post bulbectomy. Regenerating axons extended over a larger volume in the operated cavity in the treatment group compared to control group at 14 days post bulbectomy. The growth factor treatment also significantly reduced astrocytic glia scar in the operated cavity. The results indicate that the combined delivery of the growth factors has the potential to improve olfactory dysfunction.

Citing Articles

Olfactory Effects of Chemotherapy Combined with Bevacizumab on Advanced-Stage Colorectal Cancer Patients: Chemotherapy and Olfaction.

Uzunoglu E, Ceylan A, Eravci F, Sahin M, Cebeci S, Yazici O Indian J Otolaryngol Head Neck Surg. 2025; 77(2):939-942.

PMID: 40070748 PMC: 11890894. DOI: 10.1007/s12070-024-05307-1.

Beyond vessels: unraveling the impact of VEGFs on neuronal functions and structure.

Aksan B, Mauceri D J Biomed Sci. 2025; 32(1):33.

PMID: 40050849 PMC: 11884128. DOI: 10.1186/s12929-025-01128-8.

Pharmacovigilance imbalance analysis of VEGFR-TKI-related taste and smell disorders.

Fu Z, Zhao C, Wang Y, Zhang L, Wang L Sci Rep. 2025; 15(1):3118.

PMID: 39856344 PMC: 11760945. DOI: 10.1038/s41598-025-87678-1.

Olfactory dysfunction and the role of stem cells in the regeneration of olfactory neurons.

Yu P, Chen W, Jiang L, Jia Y, Xu X, Shen W Heliyon. 2024; 10(9):e29948.

PMID: 38694081 PMC: 11058886. DOI: 10.1016/j.heliyon.2024.e29948.

Gene expression and locomotor recovery in adult rats with spinal cord injury and plasma-synthesized polypyrrole/iodine application combined with a mixed rehabilitation scheme.

Coyoy-Salgado A, Orozco-Barrios C, Sanchez-Torres S, Olayo M, Cruz G, Morales-Corona J Front Neurol. 2023; 14:1124245.

PMID: 37288064 PMC: 10243140. DOI: 10.3389/fneur.2023.1124245.

References

Nota J, Takahashi H, Hakuba N, Hato N, Gyo K . Treatment of neural anosmia by topical application of basic fibroblast growth factor-gelatin hydrogel in the nasal cavity: an experimental study in mice. JAMA Otolaryngol Head Neck Surg. 2013; 139(4):396-400. DOI: 10.1001/jamaoto.2013.92. View

Chehrehasa F, Meedeniya A, Dwyer P, Abrahamsen G, Mackay-Sim A . EdU, a new thymidine analogue for labelling proliferating cells in the nervous system. J Neurosci Methods. 2008; 177(1):122-30. DOI: 10.1016/j.jneumeth.2008.10.006. View

Kobayashi M, Costanzo R . Olfactory nerve recovery following mild and severe injury and the efficacy of dexamethasone treatment. Chem Senses. 2009; 34(7):573-80. PMC: 2728832. DOI: 10.1093/chemse/bjp038. View

de Kruijk J, Leffers P, Menheere P, Meerhoff S, Rutten J, Twijnstra A . Olfactory function after mild traumatic brain injury. Brain Inj. 2003; 17(1):73-8. DOI: 10.1080/0269905021000010221. View

Ekberg J, Amaya D, Chehrehasa F, Lineburg K, Claxton C, Windus L . OMP-ZsGreen fluorescent protein transgenic mice for visualisation of olfactory sensory neurons in vivo and in vitro. J Neurosci Methods. 2011; 196(1):88-98. DOI: 10.1016/j.jneumeth.2011.01.008. View

Schanzer A, Wachs F, Wilhelm D, Acker T, Cooper-Kuhn C, Beck H . Direct stimulation of adult neural stem cells in vitro and neurogenesis in vivo by vascular endothelial growth factor. Brain Pathol. 2004; 14(3):237-48. PMC: 8096047. DOI: 10.1111/j.1750-3639.2004.tb00060.x. View

Ramirez-Rodriguez G, Perera-Murcia G, Ortiz-Lopez L, Vega-Rivera N, Babu H, Garcia-Anaya M . Vascular endothelial growth factor influences migration and focal adhesions, but not proliferation or viability, of human neural stem/progenitor cells derived from olfactory epithelium. Neurochem Int. 2017; 108:417-425. DOI: 10.1016/j.neuint.2017.06.001. View

Schiffman S . Taste and smell losses in normal aging and disease. JAMA. 1997; 278(16):1357-62. View

Pinto J, Wroblewski K, Kern D, Schumm L, McClintock M . Olfactory dysfunction predicts 5-year mortality in older adults. PLoS One. 2014; 9(10):e107541. PMC: 4182669. DOI: 10.1371/journal.pone.0107541. View

10.

London B, Nabet B, Fisher A, White B, Sammel M, Doty R . Predictors of prognosis in patients with olfactory disturbance. Ann Neurol. 2007; 63(2):159-66. DOI: 10.1002/ana.21293. View

11.

Mohapel P, Frielingsdorf H, Haggblad J, Zachrisson O, Brundin P . Platelet-derived growth factor (PDGF-BB) and brain-derived neurotrophic factor (BDNF) induce striatal neurogenesis in adult rats with 6-hydroxydopamine lesions. Neuroscience. 2005; 132(3):767-76. DOI: 10.1016/j.neuroscience.2004.11.056. View

12.

Chehrehasa F, Cobcroft M, Young Y, Mackay-Sim A, Goss B . An acute growth factor treatment that preserves function after spinal cord contusion injury. J Neurotrauma. 2014; 31(21):1807-13. DOI: 10.1089/neu.2013.3294. View

13.

Temmel A, Quint C, Schickinger-Fischer B, Klimek L, Stoller E, Hummel T . Characteristics of olfactory disorders in relation to major causes of olfactory loss. Arch Otolaryngol Head Neck Surg. 2002; 128(6):635-41. DOI: 10.1001/archotol.128.6.635. View

14.

Nishikawa T, Doi K, Ochi N, Katsunuma S, Nibu K . Effect of intranasal administration of basic fibroblast growth factor on olfactory epithelium. Neuroreport. 2009; 20(8):764-9. DOI: 10.1097/WNR.0b013e32832b169e. View

15.

Lutton C, Young Y, Williams R, Meedeniya A, Mackay-Sim A, Goss B . Combined VEGF and PDGF treatment reduces secondary degeneration after spinal cord injury. J Neurotrauma. 2011; 29(5):957-70. DOI: 10.1089/neu.2010.1423. View

16.

Pozzi A, Yovanovich C, Jungblut L, Heer T, Paz D . Immunohistochemical localization of vascular endothelial growth factor and its receptor Flk-1 in the amphibian developing principal and accessory olfactory system. Anat Embryol (Berl). 2006; 211(5):549-57. DOI: 10.1007/s00429-006-0105-1. View

17.

Chehrehasa F, St John J, Key B . The sorting behaviour of olfactory and vomeronasal axons during regeneration. J Mol Histol. 2006; 36(6-7):427-36. DOI: 10.1007/s10735-006-9015-z. View

18.

Aiba T, Mori J, Nakai Y . Nerve growth factor (NGF) and its receptor in rat olfactory epithelium. Acta Otolaryngol Suppl. 1993; 506:37-40. DOI: 10.3109/00016489309130238. View

19.

Norazit A, Nguyen M, Dickson C, Tuxworth G, Goss B, Mackay-Sim A . Vascular endothelial growth factor and platelet derived growth factor modulates the glial response to a cortical stab injury. Neuroscience. 2011; 192:652-60. DOI: 10.1016/j.neuroscience.2011.06.035. View

20.

Wittko I, Schanzer A, Kuzmichev A, Schneider F, Shibuya M, Raab S . VEGFR-1 regulates adult olfactory bulb neurogenesis and migration of neural progenitors in the rostral migratory stream in vivo. J Neurosci. 2009; 29(27):8704-14. PMC: 3865485. DOI: 10.1523/JNEUROSCI.5527-08.2009. View